We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Aegerion’s Warning Letter for False Heart Drug Claims Is Closed Out
Aegerion’s Warning Letter for False Heart Drug Claims Is Closed Out
Aegerion Pharmaceuticals said the FDA has closed out a warning letter stemming from overblown claims its CEO made on TV, but the company still faces a federal investigation and lawsuit surrounding its marketing practices.